Liu Yue Bo

Volume 33 Issue 11

Turn off MathJax

Article Contents

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2012 > 33(11):

PDF( 200 KB)

Liu Yue Bo

Abstract

FullText(HTML)

References(0)

References

Relative Articles(20)

Relative Articles

[1]	Haoran XING, Xi ZHANG, Yingying ZHANG, Tianhao BAO. Advancements in the Clinical Use of Antidepressants for Adolescent Depression. Journal of Kunming Medical University, 2024, 45(7): 168-176. doi: 10.12259/j.issn.2095-610X.S20240725
[2]	Chunling LI, Linghua LI, Xu HAN, Jie YANG, Heng ZHANG. Clinical Observation of Treating Ulcerative Colitis with Acupuncture at Front Mu Points Combined with Oral Mesalazine. Journal of Kunming Medical University, 2024, 45(3): 72-78. doi: 10.12259/j.issn.2095-610X.S20240311
[3]	Liyuan YUN, Junfeng WANG, Ning GUO, Ruimei DING, Haipeng LI, Xueping ZHANG. Analysis of the Efficacy and Safety of GM1 Injection Combined with Batroxobin in the Treatment of Sudden Deafness Patients. Journal of Kunming Medical University, 2024, 45(6): 140-144. doi: 10.12259/j.issn.2095-610X.S20240619
[4]	Lanzhu YAN, Shunyi QIAO, Yanli ZHANG, Erqiang ZHAO, Hu YANG, Jing LIN, Haiyan FU. Changes of Immunoglobulin in TACE Treatment of Hepatocellular Carcinoma and Its Value in Predicting Curative Effect. Journal of Kunming Medical University, 2024, 45(4): 128-134. doi: 10.12259/j.issn.2095-610X.S20240418
[5]	Fen TENG, Bo TIAN, Chongxi LI, Yongmei JIN, Haiyun CHEN, Jun LIU. Real-World Clinical Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide （BIC/FTC/TAF） Single-Tablet Regimen. Journal of Kunming Medical University, 2024, 45(4): 74-80. doi: 10.12259/j.issn.2095-610X.S20240411
[6]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[7]	Yanling JIN, Jianmei LI. Efficacy and Safety of rhTPO Combined with High-dose Short-cycle Dexamethasone Regimen in Treatment of ANa-positive Adult Immune Thrombocytopenia. Journal of Kunming Medical University, 2022, 43(11): 146-150. doi: 10.12259/j.issn.2095-610X.S20221119
[8]	Zhi-rong ZHAO, Hai-wen LI, Xiao-fei LI, Ni-hong LU, Yong-rui YANG. Efficacy and Safety of Sofosbuvir/Vipatavir Combined with Ribavirin in Treatment of Genotype 3 Patients with Chronic Hepatitis C. Journal of Kunming Medical University, 2021, 42(3): 98-103. doi: 10.12259/j.issn.2095-610X.S20210325
[9]	Pan Zi Peng . Analysis and Safety Evaluation of the Clinical Efficacy of Laparoscopic Appendectomy for Acute Appendicitis. Journal of Kunming Medical University,
[10]	Hu Wei Hua . The Observation of Clinical Effect of Using Ambroxol in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Kunming Medical University,
[11]	Zhao Li Dong . Clincal Effect of Different Doses of Esomeprazole in Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding. Journal of Kunming Medical University,
[12]	Shang Xue Qin . . Journal of Kunming Medical University,
[13]	Zeng Hai Ping . . Journal of Kunming Medical University,
[14]	Wang Ji Cai . . Journal of Kunming Medical University,
[15]	Li Hai Feng . . Journal of Kunming Medical University,
[16]	Ren Hong Xuan . . Journal of Kunming Medical University,
[17]	Hu Hai Yan . . Journal of Kunming Medical University,
[18]	. . Journal of Kunming Medical University,
[19]	Wang Ji Cai . . Journal of Kunming Medical University,
[20]	Yang Xi Yun . . Journal of Kunming Medical University,

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	丁妍华，门帅，张江霞，张旭，张善存，刘璐，吕宏伟，肖正红. 贝伐珠单抗联合安罗替尼治疗非小细胞肺癌的临床疗效及对免疫状态的影响. 哈尔滨医药. 2024(01): 41-44 .
2.	解燕茹. 安罗替尼联合伊立替康和洛铂二线治疗晚期小细胞肺癌的临床研究. 基层医学论坛. 2024(07): 51-53 .
3.	张全，曹志坤，丁成智，刘孟博，李基伟，魏立. 安罗替尼通过核因子信号通路抑制非小细胞肺癌细胞增殖、迁移和侵袭并促进细胞凋亡. 中华实验外科杂志. 2024(12): 2778-2782 .
4.	王帅，刘景春. 安罗替尼联合TC化疗方案治疗驱动基因阴性晚期肺腺癌患者的效果. 河南医学研究. 2023(05): 912-916 .
5.	林征，周进，黄开荣. 安罗替尼联合AN方案一线治疗晚期野生型肺腺癌的回顾性研究. 中国医学创新. 2023(31): 32-37 .
6.	马闻. 替雷利珠单抗联合安罗替尼治疗晚期肺腺癌的效果及对血清肿瘤标志物的影响. 中国医学创新. 2022(17): 124-127 .